Results 161 to 170 of about 50,344 (211)

Optimizing the therapeutic benefits of synriam combined with praziquantel in mice harbouring juvenile and mature Schistosoma mansoni. [PDF]

Sci Rep
Sabra AA, Salem MB, William S, Hammam OA, El-Lakkany NM.   +4 more
europepmc   +1 more source

Acetylene Acetogenin from <i>Porcelia macrocarpa</i> Exhibits Superior Efficacy against <i><i>Schistosoma mansoni</i> In Vivo</i>. [PDF]

ACS Omega
Souza DCS, Brito IA, Oliveira EA, Cajás RA, Teixeira TR, de Moraes J, Lago JHG.   +6 more
europepmc   +1 more source

The relationship between expelled eggs, morbidity and age in a Schistosoma mansoni endemic setting in Uganda: Implications for current elimination policies. [PDF]

PLoS Negl Trop Dis
Lim RM, Lahoti R, Clark J, Arinaitwe M, Anguajibi V, Alonso S, Nankasi A, Besigye F, Atuhaire A, Pedersen AB, Webster JP, Lamberton PHL.   +11 more
europepmc   +1 more source

A comparative parasitological, histopathological, and proteomic analysis of <i>Schistosoma mansoni</i> infected mice treated with ivermectin and praziquantel. [PDF]

Front Vet Sci
El-Wakil ES, Tolba MM, El-Sayad MH, Khairy Hassen M, Al-Rashidi HS, Almayouf MA, Al-Megrin WAI, Alzaylaee H, Moneer EA.   +8 more
europepmc   +1 more source

Benzodeazaoxaflavin Sirtuin Inhibitors Inhibit <i>Schistosoma mansoni</i> Sirt2 and Cause Phenotypic Changes and Lethality in Schistosomula and Adult Worm Stages. [PDF]

ACS Infect Dis
Gimmelli R, Papoff G, Fabbrizi E, Guida M, Lalli C, Saccoccia F, Häberli C, Keiser J, Monaldi D, Jung M, Romier C, Rotili D, Mai A, Ruberti G.   +13 more
europepmc   +1 more source

Prevalence of schistosome infection among children under two years of age: a brief report from medium-to-high endemic regions of Schistosoma mansoni in Madagascar. [PDF]

Trop Med Health
Kislaya I, Rakotoarivelo RA, Rasamoelina T, Solonirina J, Brito A, Ratiaharison EF, Razafindrakoto R, Razafindralava NM, Rakotozandrindrainy N, Radomanana M, Andrianarivelo MR, Klein P, Jaeger A, Lorenz E, Hameister J, Hoekstra PT, Corstjens PLAM, Schwarz NG, van Dam GJ, May J, Marchese V, Rakotozandrindrainy R, Fusco D, freeBILy consortium.   +23 more
europepmc   +1 more source

Co-occurrence of alcohol use and Schistosoma mansoni infection: prevalence, patterns, and risk factors in rural Uganda

Lyne B, Besong ME, Nabatte B, Tinkitina B, Oryema JB, Kabatereine NB, Lewington S, Chami GF.   +7 more
europepmc   +1 more source

Uncovering the role of the gut microbiome and metabolome in Schistosoma mansoni-induced modulation of cardiovascular disease risk in humans

Walusimbi B, Lawson MA, Bancroft AJ, Nassuuna J, Trivedi DK, Taylor G, Sanya RE, Webb EL, Kateete DP, Grencis RK, Elliott AM.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Immunoregulation by Schistosoma mansoni

Immunopharmacology, 1981
Schistosoma mansoni is known to release an inhibitory factor of lymphocyte proliferation elicited in vitro. The effect of this dialyzable schistosome incubation product (DSIP) was tested in vivo on different aspects of the cell-mediated immune response.
D, Camus, A, Nosseir, C, Mazingue, A, Capron   +3 more
openaire   +2 more sources

Phosphomonoesterases of Schistosoma mansoni

Experimental Parasitology, 1963
Abstract Extracts of adult Schistosoma mansoni were shown to contain high concentrations of both acid and alkaline phosphomonoesterases. In vitro investigations of the enzymes were made with regard to pH optima in different buffers, rates of hydrolysis of and affinities for several phosphomonoesters, stability, and response to activators and ...
R H, NIMMO-SMITH, O D, STANDEN
openaire   +2 more sources